FEATURED SPEAKERS: Nadim Ahmed, President & CEO, Cullinan Oncology Samuel Blackman, M.D., Ph.D., Head of Research and Development & Co-Founder, Day One BiopharmaceuticalsMarianne De Backer, M.Sc., Ph.D., MBA, CEO, Vir Biotechnology, Inc. Dr. Laura Gault, M.D., Ph.D., Chief Medical Officer, Sage TherapeuticsWilliam Grossman, M.D., Ph.D., SVP - Oncology Clinical Development, Therapeutic Area Head, Gilead Sciences Rachel King, CEO, Biotechnology Innovation Organization (BIO)Marian Nakada, Ph.D., Vice President, Venture Investments, Johnson & Johnson InnovationJoseph Panetta, President & CEO, Biocom California Peter Pitts, President, Center for Medicine in the Public Interest, and Former FDA Associate Commissioner Maha Radhakrishnan, M.D., Group SVP and Chief Medical Officer, Biogen Devyn Smith, CEO, Arbor Biotechnologies, and Chairman of ARM Ryan Spencer, CEO, Dynavax Technologies Uli Stilz, Vice President, Novo Nordisk Bio Innovation HubScott Weintraub, SVP, US Commercial Operations, AlexionAlice Zhang, CEO and Co-Founder, Verge Genomics |